Inventor · disambiguated record
Stephane Ciblat
Also filed as: CIBLAT STEPHANE · CIBLAT STÉPHANE
40 granted patents·25 pending applications·113 citations·filing 2006–2025
97Inventor score
Files withSYROS PHARMACEUTICALS INC27VENTUS THERAPEUTICS U S INC8BANTAM PHARMACEUTICAL LLC5KONG XIANQI5PYRAMID BIOSCIENCES INC4
Top patents by PatentIndex Score
65 records- 0194US10738067B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2020·Granted Aug 11, 2020·5 cites·30 claims
- 0294US8748656B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidKONG XIANQI·Filed 2007·Granted Jun 10, 2014·17 cites·14 claims
- 0393US11040957B2Heteroaromatic compounds useful for the treatment of proliferative diseasesSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·7 cites·21 claims
- 0492US10059690B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·9 cites·19 claims
- 0591US11858915B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted Jan 2, 2024·3 cites·21 claims
- 0691US10047070B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2014·Granted Aug 14, 2018·17 cites·19 claims
- 0791US9499480B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBHI LTD PARTNERSHIP·Filed 2014·Granted Nov 22, 2016·10 cites·13 claims
- 0890US10857109B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2019·Granted Dec 8, 2020·3 cites·11 claims
- 0989US11739096B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2022·Granted Aug 29, 2023·1 cites·2 claims
- 1089US10238611B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBHI LP·Filed 2016·Granted Mar 26, 2019·6 cites·9 claims
- 1188US12398136B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2024·Granted Aug 26, 2025·0 cites·18 claims
- 1287US12312351B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2024·Granted May 27, 2025·0 cites·20 claims
- 1386US12410167B2Pyridazine compounds for inhibiting NLRP3VENTUS THERAPEUTICS U S INC·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 1486US10308648B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·6 cites·20 claims
- 1585US10106526B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·5 cites·19 claims
- 1684US11020360B2Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2020·Granted Jun 1, 2021·1 cites·8 claims
- 1784US10906889B2Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)DANA FARBER CANCER INST INC·Filed 2018·Granted Feb 2, 2021·4 cites·32 claims
- 1884US10519135B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·3 cites·18 claims
- 1983US12331048B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2023·Granted Jun 17, 2025·0 cites·18 claims
- 2083US12240869B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Mar 4, 2025·1 cites·27 claims
- 2183US2024409540A1PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORSVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 2282US11311542B2Inhibitors of cyclin dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Apr 26, 2022·3 cites·20 claims
- 2381US11230546B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 2479US12486276B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·6 claims
- 2579US11325903B2Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseasesBANTAM PHARMACEUTICAL LLC·Filed 2017·Granted May 10, 2022·2 cites·24 claims
- 2679US11124527B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 21, 2021·2 cites·30 claims
- 2779US10865206B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·1 cites·25 claims
- 2878US11602526B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2020·Granted Mar 14, 2023·1 cites·27 claims
- 2977US10537558B2Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating theretoBANTAM PHARMACEUTICAL LLC·Filed 2016·Granted Jan 21, 2020·3 cites·28 claims
- 3074US2021386693A1Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acidBELLUS HEALTH INC·Filed 2021·Application pending·0 cites
- 3172US2024360165A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3271US2023144106A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3370US12312339B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted May 27, 2025·0 cites·22 claims
- 3470US2022235055A15-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3568US9051248B2Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acidKONG XIANQI·Filed 2010·Granted Jun 9, 2015·1 cites·21 claims
- 3665US2024270722A1Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3765US2021061803A1Inhibitors of cyclin-dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3865US2024368131A1Oxoindolinyl amide derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 3964US2023076820A1Substituted Pyrazole Compounds and Methods of Using Them for Treatment of Hyperproliferative DiseasesBANTAM PHARMACEUTICAL LLC·Filed 2022·Application pending·0 cites
- 4064US2024270740A1Inhibitors of cyclic gmp-amp synthase and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 4163US11753418B2Compounds for the modulation of Myc activitySYROS PHARMACEUTICALS INC·Filed 2021·Granted Sep 12, 2023·0 cites·30 claims
- 4262US2021188833A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4362US2022305014A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4461US2023062491A1Inhibitors of cyclin dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4560US2016264551A1Heteroaromatic compounds useful for the treatment of prolferative diseasesSYROS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4659US2021221820A1Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4757US2021147431A1Pyrrolotriazine compounds and methods of inhibiting tam kinasesSYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4855US10787444B2Compounds for the modulation of myc activitySYROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 29, 2020·0 cites·25 claims
- 4954US2025304537A1Heteroarenes, pharmaceutical compositions containing the same, and methods of using the sameREPARE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 5054US2025257077A1BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORSVENTUS THERAPEUTICS U S INC·Filed 2025·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephane Ciblat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →